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Small-dose, multiple injections of GnRH given to seasonally anoestrous ewes induce ﬁnal
stages of the preovulatory follicle development, but result in an high incidence of defective
CL unless animals are primed with progesterone, which completely eliminates luteal
dysfunction. Progesterone priming upregulates luteal vascularization; however, its effect
on follicular angiogenesis is poorly understood. This study tested the hypothesis that
progesterone priming of seasonally anoestrous ewes treated with dose multiple injections
of GnRH eliminates defective luteal function by altering the expression of vascular endo-
thelial growth factor (VEGF), VEGF receptor-2, angiopoietin (ANG)-1, ANG-2, and TIE-2
during early and late preovulatory follicle development. Ten seasonally anoestrous ewes
were given 20 mg of progesterone im 3 days before the start of GnRH treatment; 10 other
animals served as controls. Intravenous injections of 500 ng GnRH were given to all ani-
mals every 2 hours for 28 hours, followed at 30 hours with a 300-mg GnRH bolus injection
to synchronize the preovulatory LH surge. Ovaries were collected at 24 and 46 hours after
the start of GnRH treatment. Small (2–2.5 mm) and large (>2.5 mm) follicles were
analyzed for protein and mRNA expression of the angiogenic factors using immunohis-
tochemistry and in situ hybridization assays. Progesterone priming did not have an in-
ﬂuence on angiogenic factor levels in small follicles. However, progesterone-primed
animals showed signiﬁcantly (P  0.05) higher levels of VEGF, VEGFR-2, ANG-1, and ANG-2
in large follicles compared with nonprimed ones. These data suggest that progesterone
priming alters the expression of angiogenic factors in large preovulatory follicles, ensuring
adequate luteal development and function.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Infertility is a major issue in animal and human medi-
cine [1], with defective luteal function being attributed as
one of its signiﬁcant causes [2]. Luteal dysfunction is a
relatively common occurrence in livestock reproduction at
the beginning of puberty or post-partum [3,4] and seasonal
[5] anestrus. Ovulation of a healthy and mature follicle is9; fax: þ44 (0)1707
. All rights reserved.
5paramount to normal luteal development and function.
The lack of understanding of the factors involved in
follicular development and maturation pose limitations to
the development of successful fertility protocols. Season-
ally anoestrous ewes induced to ovulate with repeated
small doses of GnRH have been widely used as a model to
study luteal function as it drives the ﬁnal stages of pre-
ovulatory follicle development leading to the induction of
ovulation [6–10]. However, inadequate luteal function is
present in the vast majority of these animals unless they
have been primed with progesterone before GnRH therapy
[8,9]. This pattern of defective luteal function has been
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ovulation [7–9,11].
It has been suggested that the inﬂuence of progesterone
on subsequent luteal functionality starts early in follicular
development, affecting dominant follicle characteristics
and development before ovulation because priming
seasonally anestrous ewes with progesterone 3 to 5 days
before the start of GnRH treatment ensures normal luteal
function in majority of the animals [8,12]. However, evi-
dence to support such suggestions has remained elusive.
To support the increasing blood ﬂow during follicular
development, the theca capillaries undergo extensive
angiogenesis [13], mainly regulated by the members of the
vascular endothelial growth factor (VEGF) and the angio-
poietin (ANG) family [14–17]. Vascular endothelial growth
factor is essential for follicular development and function
because it stimulates endothelial cell proliferation and
migration, maintains immature blood vessel viability [18],
and ensures endothelial cell survival through the phos-
phorylation of its main receptor VEGF receptor (R)-2 (Flk-1)
[19]. After the initial stages of vascular development, ANG-
1 is responsible for vascular stabilization and maturation
[20], whereas ANG-2 is involved in destabilization of
existing vessels [15]. Both ANG-1 and -2 bind to the TIE-2
receptor with similar afﬁnity and thus act as antagonists
by competing for the same receptor [21]. The ANG-2:ANG-1
ratio is used as an index of vascular stabilization in
conjunctionwith VEGF levels [22].When the ANG-2:ANG-1
ratio and VEGF levels are high, new blood vessel networks
are formed. However, when the ANG-2:ANG-1 ratio is high
but VEGF levels are low, regression of blood vessels hap-
pens and a low ANG-2:ANG-1 ratio along with relatively
low levels of VEGF result in stabilization of blood vessels
[23].
Because vascularity and normal ovarian function are
closely related [16,17,24], it is a possibility that inadequate
development of the microvasculature of the preovulatory
follicle may be the underlying cause of defective luteal
function in nonprimed GnRH-treated seasonally anestrous
ewes, and that this problem might overcome by
progesterone-induced changes in the vascularity of the
preovulatory follicle.
Around the time of ovulation, extensive changes take
place in the theca and granulosa layers of the preovulatory
follicle to form the CL [17]. To meet the demands of these
cells, a well-established vascular supply is essential for
normal luteal development [25]. A disruption in the normal
delicate balance of angiogenesis within the preovulatory
follicle could lead to inadequate development of the
follicular microvasculature, resulting in poor vasculariza-
tion of the newly formed CL and thus be responsible for the
observed defective luteal function [9], a deﬁciency that is
overcome by progesterone priming. The current study was
undertaken to test the hypothesis that progesterone
priming of the GnRH-treated seasonally anoestrous ewes
alters the expression of angiogenic growth factors in the
ovarian follicles. This was done by monitoring VEGF, the
ANGs, and their receptors in small and large follicles of
progesterone primed and nonprimed seasonally anestrous
ewes treated with small-dose multiple injections of GnRH
sufﬁcient to induce ovulation.2. Materials and methods
2.1. Animals and treatments
The experiment was conducted in August during the
non-breeding season at Aberystwyth University, UK (lati-
tude 5225’N) using 20 adult seasonally anoestrous Welsh
Mule ewes (Ovis aries). These eweswere in anoestrus at this
time of the year because their breeding season starts in mid
October in the northern hemisphere. All treatments were
given in compliance with the Guide for the Care and Use of
Agricultural Animals in Agricultural Research under the UK
Home Ofﬁce authorization (Animal Scientiﬁc Procedures
Act, 1986). Half of the ewes received a single im injection of
20 mg progesterone (Sigma-Aldrich, Dorset, England) in
corn oil 3 days before the start of GnRH treatment, whereas
the other half received corn oil vehicle alone. Each ewe had
its jugular vein cannulated and received 500 ng GnRH (LH-
releasing hormone human acetate salt, Sigma-Aldrich) in 2
mL of sterile normal saline solution intravenously every 2
hours for 28 hours to induce LH pulses, followed by a bolus
injection of 300 mg GnRH at 30 hours after the start of GnRH
treatment to synchronize the onset of the preovulatory LH
surge, as described previously [26]. Animals were killed
with an overdose of pentobarbital sodium (Merial Animal
Health Ltd., Harlow, UK) and ovaries were collected from all
the animals in each treatment group at either 24 or 46
hours after the start of GnRH treatment. These time periods
were designed to provide follicles either 6 hours before or
16 hours after the onset of the preovulatory LH surge but
before the time of ovulation, respectively.
2.2. LH monitoring
Blood samples were collected from all animals at 15-
minutes intervals for the ﬁrst 4 hours from the start of
GnRH treatment to monitor LH pulses (maximum con-
centration <3 ng/mL), and thereafter at 2-hour intervals
until either euthanasia or 16 hours after the GnRH bolus
injection to monitor the preovulatory LH surge (>10 ng/
mL). Plasma was separated by centrifugation of the blood
samples at 1500 rpm for 10 minutes at 4 C and stored at
20 C until analyzed for LH. We measured LH using a
sandwich-type ELISA assay (LH DETECT, INRA Centre de
Tours-PRC, Nouzilly, France) and performed as recom-
mended by the manufacturer.
2.3. Sample collection
Immediately after collection, ovaries were washed in
PBS pH 7.4 and ﬁxed in 40% v/v neutral buffered formalin
(BDH, Poole, Dorset, UK) for 24 hours and then preserved in
70% v/v ethanol until embedded in Parafﬁn wax (Paraplast,
Leica, Taab Laboratories Equipment Ltd., Aldermason, UK).
2.4. Slide preparation and ovary mapping
Wax-embedded tissue samples were sectioned (6 mm)
and mounted onto SuperFrost Plus slides (BDH, VWR
International, Lutterwoth, UK) for immunohistochemi-
stry and in situ hybridization analyses. To identify and
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staining every 25th slide with hematoxylin and eosin, as
previously described [27]. In summary, the hematoxylin
and eosin–stained sections were placed under a stereo-
scope (Leica, Wetzlan, Germany), the follicles were identi-
ﬁed and their diameter measured using an ocular scale.
Follicles were tracked across sections and maximum
follicular diameter was used to categories follicles into
small (2–2.5mm) and large (>2.5mm). Three cellular layers
(granulosa, theca interna, and theca externa) of the follicles
were used for analysis. A total of 91 small and 79 large
follicles were used for immunohistochemistry and in situ
hybridization analysis of each angiogenic factor.
2.5. Immunohistochemistical analysis
Immunohistochemistical assays for the proteins of in-
terest were performed on consecutive sections of a follicle
using the avidin-biotin peroxidase method as previously
described [27–30], but with secondary antibody concen-
tration of 1:25 biotinylated goat anti-rabbit IgG (Vector
Laboratories, Burlingame, CA) in 2% v/v normal goat serum
in PBS and color detection being performed using ImmPACT
DAB (Vector Laboratories).
For VEGF, sections were incubated in 1:100 rabbit
polyclonal anti-human VEGF antibody at 200 mg/mL
(VEGFA-20, Santa Cruz Biotechnologies, Heidelberg, Ger-
many) in PBS overnight at 4 C and then left to develop
color for 1 minute. For VEGFR-2, incubation took place
overnight in 1:50 rabbit polyclonal anti-mouse FLK-1
(VEGFR-2) at 200 mg/mL (Santa Cruz Biotechnologies) at
4 C. Slides were left to develop color for 2 minutes. For
ANG-1, a 1:200 concentration of rabbit polyclonal anti-
mouse ANG-1 at 85 mg/mL (Abcam Inc., Cambridge, MA)
was used for 1 hour and slides were left to develop color for
2 minutes. For ANG-2, 1:100 Rabbit polyclonal anti-human
ANG-2 at 200 mg/ml (Abcam) was used for 1 hour and color
developed for 2 minutes. For TIE-2, 1:100 rabbit polyclonal
anti-mouse TIE-2 at 200 mg/ml (C-20, Santa Cruz Bio-
technologies) was used for 1 hour and slides were left for
30 seconds to develop color. For the negative control sec-
tions the same protocol was followed except that the pri-
mary antibody was replaced by rabbit IgG (Santa Cruz
Biotechnologies) at the same concentration. Positive
staining was observed as brown color (Fig. 1B, D, F, J, L),
whereas no staining was observed for negative controls
(Fig. 1A, C, E, I, K).
2.6. In situ hybridization
In situ hybridizationwas performed only forANG-1, ANG-
2, and TIE-2. Bacteria containing ovine ANG-1, ANG-2, and
TIE-2 complimentary DNA, as described previously [27],
wereprovidedbyDr. Chowdhury (DepartmentofVeterinary
Clinical Sciences, The Royal Veterinary College, North
Mymms, Hertfordshire, UK). Riboprobes for ovine ANG-1,
ANG-2, and TIE-2were synthesized using T7 (sense) and SP6
(anti-sense) MEGAscript High-Yield Transcription Kits
(Ambion Ltd., Cambridgeshire, UK) after linearization of
plasmidswith Sal I andApa I, respectively. During synthesis,
riboprobes were labeled with digoxogenin-II–uridinetriphosphate (Roche Applied Bioscineces, Welwyn Garden
City, England, UK) for nonradioactive detection following
the manufacturer’s recommendations. In situ hybridization
was performed according to the technique described
by Kershaw, et al. [28] and Chowdhury, et al. [27]. ANG-1,
ANG-2, and TIE-2 hybridization was performed for 19 hours
in a humidiﬁed chamber at 60 C and color development
took place for 20 hours before mounting. Positive staining
was observed as brown color for antisense riboprobes
(Fig. 2B, D, F); no staining was observed for sense (control)
probes (Fig. 2A, C, E).
2.7. Quantiﬁcation of staining for immunohistochemistry and
in situ hybridization
The pattern and intensity of protein and mRNA staining
for VEGF, VEGFR-2, ANG-1, ANG-2, and TIE-2 in follicular
tissue were determined semi-quantitatively using a histo-
chemical score (HSCORE) method that has been widely
reported in a number of studies in our own laboratory
[27–30] and by others [31,32]. Moreover, the HSCORE
method of analysis used in this study has been previously
validated as a suitable method for semiquantitative esti-
mation of immunohistochemistry and in situ hybridization
results [33]. In this study, all assessments were carried out
in a blinded manner by one experienced assessor using
HSCORE, incorporating both the distribution and the in-
tensity of speciﬁc staining as described previously
[27,28,30,33,34]. Brieﬂy, the percentage of positively
stained cells and the intensity of the staining of those cells
were recorded at an original magniﬁcation of 400. The
percentage of speciﬁcally stained cells to which each in-
tensity staining corresponded was also recorded. The in-
tensity of staining was classiﬁed on a scale of 0 to 3, where
0 ¼ no visible staining, 1 ¼ weak staining, 2 ¼ moderate
staining, and 3 ¼ strong staining. Each cell layer from every
follicle, granulosa, theca interna, and theca externa was
analyzed at three randomly selected areas in each of three
positive staining sections, resulting in a total of nine posi-
tive ﬁelds analyzed per cell layer for each follicle. An
expression index was calculated for each follicle layer
based on the percentage of positively stained cells and the
intensity of staining using the following formula: Expres-
sion index ¼ % total stained cells  [(1  % weak) þ (2  %
medium) þ (3  % strong)]/100. A mean expression index
was calculated to represent the expression of each angio-
genic factor and its mRNA in each follicular cell layer of
every follicle from an individual animal.
2.8. Statistical Analysis
Data on both protein and mRNA for the different
angiogenic factors were analyzed using a linear mixed
model within the REML function of GenStat. Treatment 
time  layer was used as ﬁxed effect and animal/follicle
number as random effects. Values were transformed to log
(ANG-1 protein in small follicles and VEGF protein in large
follicles) or square root (ANG-1 and -2 mRNA in small fol-
licles and ANG-1 mRNA in large follicles) to normalize the
data before statistical analyses. Overall effects of treatment
(progesterone priming), time (before or after the LH surge),
Fig. 1. .Representative immunohistochemistry images of VEGF (A, B), VEGFR-2 (C, D), ANG-1 (E, F), ANG-2 (I, J), and TIE-2 (K, L) protein expression in ovarian
follicles of progesterone primed seasonally anoestrous ewes treated with small-dose multiple injections of GnRH. Bright ﬁeld microscopy at an original magniﬁ-
cation of 100 (C, D, E, F), 200 (A and B), and 400 (I, J, K, L). Positive and negative images are shown on the right and left, respectively. G, granulosa layer; T, theca
layer.
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Fig. 2. Representative in situ hybridization of ANG-1 (A, B), ANG-2 (C, D), and TIE-2 (E, F) mRNA expression in ovarian follicles of progesterone primed seasonally
anoestrous ewes treated with small-dose multiple injections of GnRH. Bright ﬁeld microscopy at an original magniﬁcation of 200. Anti-sense (positive) and
sense (negative) images are shown on the right and left, respectively. G, granulosa layer; T, theca layer.
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as well as three-way interactions (treatment  time 
layer) were analyzed. All analyses were performed using
GenStat 9th edition (Version 9.1.0.147, Lawes Agricultural
Trust, VSN International Ltd.). Signiﬁcance was considered
at the 5% level.
3. Results
3.1. General observations
As expected, small-dose multiple injections of GnRH
successfully induced LH pulses, which did not exceed 3 ng/
mL, whereas the GnRH bolus injection given at 30 hours
after the start of GnRH treatment induced an LH surge (>10
ng/mL) in all the animals. Based on the LH proﬁle for each
group, it was clear that ovaries collected at 24 hours after
the start of the GnRH treatment were collected before the
LH surge and ovaries collected 46 hours after the start ofGnRH treatment were collected 16 hours after the start of
the LH surge and approximately 14 hours before the ex-
pected ovulation time. The lack of ovulation in these groups
was further conﬁrmed by the absence of a corpus haemor-
rhagicum and/or an ovulation point at the time of ovary
collection.
3.2. Expression of angiogenic factors and their receptors in
small follicles
In small follicles, VEGF protein expression was not
affected by progesterone priming treatment, however, its
expression was signiﬁcantly greater (P < 0.05) in follicles
collected before the LH surge. Neither the progesterone
treatment nor the time had any effect on the protein or the
mRNA expression of VEGFR-2, ANG-1, ANG-2, and TIE-2 in
small follicles. Protein expression for VEGF, VEGFR-2, ANG-
1, ANG-2, and TIE-2 was signiﬁcantly greater (P < 0.05) in
the theca interna than the granulosa or theca externa
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was highest in the granulosa layer, there was no difference
in the TIE-2mRNA expression among the different follicular
layers of the small follicles.
3.3. Expression of angiogenic factors and their receptors in
large follicles
Expression of VEGF protein was signiﬁcantly greater
(P < 0.05) in large follicles of progesterone primed than
nonprimed animals (Fig. 3), and in follicles collected before
than after the LH surge (Fig. 4). In addition, VEGF protein
expression was signiﬁcantly (P < 0.05) greater in the theca
interna compared with the theca externa and granulosa
layers (data not shown), with no interaction (P ¼ 0.98)
between progesterone priming, time relative to the LH
surge, and the follicular layer.
Although neither progesterone priming (P ¼ 0.14) nor
time of collection of follicles relative to the LH surge (P ¼
0.55) had any effect on the overall VEGFR-2 protein
expression in large follicles, the theca interna had signiﬁ-
cantly (P < 0.05) higher protein expression than the other0
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Fig. 4. Mean Log10 expression of vascular endothelial growth factor (VEGF)
protein before and after the preovulatory LH surge in large follicles of
seasonally anoestrous ewes treated with small-dose multiple injections of
GnRH. Log10 s.e.d. ¼ 0.058, standard error of difference to compare the
mean values for VEGF expression before and after the LH surge. Different
letters on bars indicate signiﬁcant difference at P  0.05.two follicular layers, with a signiﬁcant (P< 0.05) three-way
interaction between factors largely attributable to lower
levels in the theca interna in follicles collected before the
LH surge and higher levels in this same layer after the LH
surge (Fig. 5).
Although there was no overall effect of either proges-
terone priming or time of collection of follicles relative to
the LH surge on ANG-1 protein expression levels in large
follicles, levels were signiﬁcantly (P < 0.05) higher in the
theca interna layer than either the theca externa or gran-
ulosa layers. In addition, there was a signiﬁcant (P < 0.05)
three-way interaction, and this was owing to the fact that
ANG-1 levels were higher in the theca interna of follicles
from progesterone primed ewes after the LH surge (Fig. 6).
Neither progesterone priming (P ¼ 0.17) nor time of
collection of follicles (P¼ 0.40) had any effect on the overall
ANG-1 mRNA expression levels in large follicles, although
levels of expression were signiﬁcantly (P < 0.05) higher
overall in the granulosa layer than either of the two thecal
layers and in the theca interna compared with the theca
externa layer. There was also a signiﬁcant (P < 0.05) three-
way interaction, again attributable to higher expression
levels of ANG-1mRNA in the theca interna of follicles from
progesterone primed ewes after the LH peak (Fig. 7).
Although there was no effect of either progesterone
priming (P ¼ 0.42) or time of collection of follicles (P ¼
0.89) on the overall ANG-2 protein expression levels in
large follicles, levels were signiﬁcantly (P < 0.05) higher in
the theca interna compared with either of the other two
follicular layers. Again, there was a signiﬁcant (P < 0.05)
three-way interaction attributable to higher levels in the
theca interna of progesterone primed ewes after the LH
surge (Fig. 8).
The ANG-2 mRNA levels in large follicles were unaf-
fected by either progesterone priming (P ¼ 0.40) or time of15
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(TI) layers of large follicles from progesterone primed and nonprimed
seasonally anoestrous ewes treated with small-dose multiple injections of
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Fig. 6. Mean Expression of ANG-1 protein in the granulosa (G), theca
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standard error of the difference for comparing mean values within and
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signiﬁcantly (P < 0.05) higher in the granulosa compared
with either of the two thecal layers but with no signiﬁcant
interactions between factors (data not shown).
Neither TIE-2 protein levels nor TIE-2mRNA expression in
large follicles were signiﬁcantly affected by progesterone
priming or timing of follicle collection relative to the LH peak.
However, TIE-2 protein levels were signiﬁcantly higher (P <
0.05) in the theca externa layer, whereas TIE-2mRNA expres-
sionwas signiﬁcantly (P< 0.05) higher in the granulosa layer.9
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Fig. 7. Mean square root expression of ANG-1 mRNA in the granulosa (G),
theca externa (TE), and theca interna (TI) layers of large follicles from pro-
gesterone primed and nonprimed seasonally anoestrous ewes treated with
small-dose multiple injections of GnRH, before and after the LH surge. The
s.e.d. ¼ 0.297, standard error of the difference for comparing mean values
within and between treatment groups.4. Discussion
The lack of extensive understanding of the factors
involved in follicular maturation and their impact on sub-
sequent luteal development [35] poses a limitation for
fertility protocols in a number of species [1,36,37].
Seasonally anoestrous ewes with and without progester-
one priming before the induction of ovulation using either
small-dose multiple injections of GnRH [7,9,10] or ram
introduction [12] have been widely used as a model to
study luteal dysfunction. We have recently reported that
progesterone priming of seasonally anoestrous ewes
induced to ovulate with small dose multiple injections of
GnRH results in a greater vascular template being available
for the newly developing CL [33]. However, the fact that
progesterone given to seasonally anoestrous ewes as early
as 3 to 5 days before the start of GnRH treatment or ram
introduction can successfully induce the formation of a
fully functional CL [12,38] suggests that progesterone
priming might ensure normal luteal function by primarily
affecting events within the preovulatory follicles whichwill
develop into these newly formed functional CL.
In this study, the 300 mg GnRH bolus injection given
intravenously 30 hours after the start of the pulsatile GnRH
treatment successfully resulted in synchronization of the
onset of the LH surge in all animals at around the time that
it would naturally occur, as reported previously [26]. This
synchronization was of extreme importance to ensure a
ﬁxed time both before and after the LH surge that initiates
the cascade of events leading to ovulation and structural
reorganization of the follicle into the developing CL
thereafter.
Adequate ovarian vasculature is essential for the de-
livery of hormones and nutrients to the developing follicle
[15,22]. Although follicular blood vessels are limited to the0
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Fig. 8. Mean expression of ANG-2 protein in the granulosa (G), theca
externa (TE), and theca interna (TI) layers of large follicles from progesterone
primed and nonprimed seasonally anoestrous ewes treated with small-dose
multiple injections of GnRH, before and after the LH surge. The s.e.d. ¼
8.943, standard error of the difference for comparing mean values within
and between treatment groups.
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for a signiﬁcant production of angiogenic factors [15],
which can diffuse to the theca compartment and/or accu-
mulate in the follicular ﬂuid creating an angiogenic
gradient attracting blood vessels closer to the granulosa
layer [39].
Angiogenesis is the formation of new blood vessels from
an already existing vascular network [16,17,40], and is
mainly regulated by the VEGF-ANG system [41]; VEGF is
essential for follicular development [13,41] and the
persistence of the theca interna capillary network is
directly dependent on VEGF accumulation in the follicular
ﬂuid [39]. Although the granulosa layer is said to be the
main source of VEGF protein production in the follicle
[13,25], it was observed in this study that VEGF protein
levels were signiﬁcantly higher in the theca interna than in
the other cellular layers of both small and large follicles.
Because the theca interna is the main source of vascular
supply to the developing follicle [39], higher expression of
VEGF protein in the theca interna is not surprising but quite
expected as a prerequisite for follicular angiogenesis. The
comparatively lower VEGF protein levels observed in the
granulosa layer in the current study could be the results of
VEGF diffusion from its site of production to the theca
interna and/or possible accumulation in the follicular ﬂuid
[39].
In small follicles, progesterone priming did not have any
signiﬁcant effect on VEGF expression before or after the LH
surge. Although it has been reported that LH stimulates
VEGF expression in the granulosa cells in vitro [15], VEGF
expression in small follicles was found to be signiﬁcantly
higher before the LH surge. The LH receptors are known to
appear in the granulosa cells of ovine follicles when they
reach approximately 3.5 mm in diameter [13]; however,
because all small follicles analyzed in this study ranged
from 2 to 2.5 mm in diameter, LH receptors may well not
have been present in the granulosa layer. This observation
leads to the conclusion that the LH surge may not have had
any direct effect of upregulating VEGF levels in small folli-
cles, probably owing to the lack of LH receptors to facilitate
such an effect. Furthermore, after the LH surge, small fol-
licles either have their development halted or undergo
atresia [10,13,42]. In either case, VEGF levels are expected to
decline [43], as observed in this study.
We found VEGFR-2 to be expressed mainly by the theca
layers of both small and large follicles, as previously re-
ported [13,43] with the highest expression being found in
the theca interna. Neither progesterone nor the LH surge
had any signiﬁcant effect on VEGFR-2 expression in small
follicles.
In small and large follicles, the theca interna layer
expressed signiﬁcantly higher levels of ANG-1 and ANG-2
protein; however, TIE-2 expression did not signiﬁcantly
vary between the cell layers. ANG-1, ANG-2, and TIE-2
mRNA was mainly expressed by the granulosa layer, in
agreement to previous reports on the ANGs mRNA
expression in the follicular layers [22,23]. This difference in
protein and mRNA expression by the different follicular
layers could possibly be explained by the diffusion of the
protein from the granulosa to the theca layer [39] or to the
follicular ﬂuid. Neither progesterone priming nor the LHsurge had any signiﬁcant effect on ANG-1, ANG-2, or TIE-2
protein or mRNA expression levels in small follicles.
The greatmajority of large follicles in this studywere 3.5
mm in diameter or greater and, therefore, expected to ex-
press LH receptors in the granulosa layer and be more
responsive to LH [13], being potential preovulatory domi-
nant follicles.
Large follicles of nonprimed animals showed signiﬁ-
cantly lower overall VEGF protein levels than those of
progesterone primed animals. The observed lower VEGF
levels in the large/potential preovulatory follicles of non-
primed animalsmay lead on one hand to the degradation of
the existing vascular bed but more importantly to the poor
vascular sprouting around the time of ovulation. Low VEGF
levels during the late follicular phase have recently been
shown to interfere with dominant follicle ovulation and
have been associated with the development of nonfunc-
tional CL [44].
Both small and large follicles had signiﬁcantly higher
VEGF expression before the LH surge. This is in agreement
with previously reported data in which VEGF levels
decrease around the periovulatory time within cells [44]
but increase markedly in follicular ﬂuid [15,40]. Although
progesterone priming resulted in a signiﬁcant increase in
VEGFR-2 protein levels of large follicles after the LH surge,
nonprimed animals showed a signiﬁcant decrease in re-
ceptor levels. Furthermore, VEGFR-2 levels observed in the
theca interna of large follicles of progesterone primed an-
imals after the LH surge were signiﬁcantly higher than
those observed in nonprimed animals. LH is known to
stimulate VEGF expression [15]. This study has shown that
LH surge has a similar effect on VEGFR-2 production.
Moreover, progesterone priming had an additive effect on
the expression of both VEGF and VEGFR2, and these
changes collectively are likely to exert their effects on
biological function.
Around the time of the LH surge, the basal membrane
between the granulosa and theca interna layers dissolves
and the theca capillaries expand and sprout into the avas-
cular granulosa layer to form a dense vascular network that
becomes the base for luteal vascular development [22].
Signiﬁcantly lower levels of VEGF and VEGFR-2 protein
observed in nonprimed animals could signiﬁcantly inter-
fere with blood vessel sprouting, thereby limiting early
luteal angiogenesis whereas an increase in VEGFR-2 protein
production by the theca interna cells of progesterone
primed animals may result in an overall increased effect of
VEGF leading to a higher degree of vascularization and
therefore, a normal luteal function in these animals.
Although in small follicles both progesterone priming
and the LH surge do not seem to affect ANG-1 protein and
ANG-1 mRNA expression levels, in large follicles proges-
terone priming signiﬁcantly upregulated ANG-1 protein
expression by the theca interna cells after the LH surge,
possibly contributing to the early luteinization process that
takes place in the cells of the ovulatory follicle [23]. The
ANG-2 protein levels in progesterone primed animals after
the LH surge were also signiﬁcantly higher than those
found in nonprimed animals. However, neither progester-
one nor the LH surge had any signiﬁcant effect on ANG-2
mRNA or TIE-2 protein and TIE-2 mRNA.
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establishment of an adequate vascular supply. Most blood
vessels of the early CL are derived from the theca layer [45]
and further vascular development originates from sprouting
from this existent vascular network [16,17,40]. High VEGF
and high Ang-2 protein levels are considered to be essential
for neovascularization to occur [23]. The signiﬁcantly lower
levels of VEGF observed in the large follicles of nonprimed
animals associated with signiﬁcantly lower levels of ANG-2
protein after the LH surge is potentially detrimental to
angiogenesis and new blood vessel formation. This is further
aggravated by the signiﬁcantly lower levels of VEGFR-2. At a
time when angiogenesis is expected to be high and theca
blood vessels are invading and sprouting into the granulosa
layer [40], low levels of angiogenic factors after the LH surge
could lead to poor sprouting of the theca capillaries and
deﬁcient neovascularization of the CL that forms from these
preovulatory follicles. Furthermore, after the LH surge, ANG-
1 and ANG-2 are thought to stimulate early luteinization and
progesterone release from the periovulatory follicle [23].
Signiﬁcantly lower levels of ANG-1 observed in nonprimed
animals after the LH surge could further interfere or delay
the initial luteinization process taking place in the follicular
layers.
In conclusion, the mechanism by which progesterone
priming eliminates defective luteal function has to date
remained elusive. However, the results of this study indi-
cate that the absence of progesterone priming leads to a
defective production of angiogenic factors in large pre-
ovulatory follicles, especially in response to the LH surge,
potentially compromising early luteal vascular develop-
ment and therefore subsequent luteal function. Such effects
are not likely to be limited to the model being used here
because there is ample evidence that the ﬁrst ovulation
during periods of transition between anoestrus (occa-
sioned by puberty, postpartum, or seasonality) and cyclic
activity [3–5,12] are associated with an high incidence of
defective luteal function. The results of the present study
strongly support the concept that the low levels of pro-
gesterone secreted by this ﬁrst short-cycle CL are the result
of defective angiogenesis within the subsequent preovu-
latory follicle(s) that could be alleviated by progesterone
exposure of these follicles before the LH surge.
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